Trials / Completed
CompletedNCT01525953
Complete Clinical Responders to Definite Chemoradiation in Esophageal Cancer : a Survival Analysis
Predictors of Survival for Complete Clinical Responders to Definite Chemoradiation or Radiation Therapy for Esophageal Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 110 (actual)
- Sponsor
- Centre Oscar Lambret · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to identify prognostic factors for outcome in patients being complete clinical responders with chemoradiation or radiation for esophageal cancer
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Chemotherapy | Chemotherapy according to standard |
| RADIATION | Radiotherapy | Radiotherapy according to local standard |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2012-01-01
- Completion
- 2012-01-01
- First posted
- 2012-02-03
- Last updated
- 2012-02-03
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01525953. Inclusion in this directory is not an endorsement.